2023 Programme

Th. 7

December

2023

 

09:25 – 09:30

WELCOMING REMARKS

ARNAUD-THYSEN
Arnaud Thysen
Director General, European Business Summits

09:30 – 09:45

► Watch the replay

OPENING CONVERSATION: "FOSTERING COMPETITION IN EUROPE: MADE IN THE EU"

image
Didier Reynders
European Commissioner for Justice
Andy-Bounds
Andy Bounds
Financial Times Correspondent

09:45 – 10:00

► Watch the replay

EXCLUSIVE INTERVIEW

lars-fruergaard-joergensen-1
Lars Fruergaard Jørgensen
CEO, Novo Nordisk
Andy-Bounds
Andy Bounds
Financial Times Correspondent

10:00 – 11:00

► Watch the replay

BUILDING A SOLID INFRASTRUCTURE FOR THE EUROPEAN DIGITAL HEALTH

The benefits of the EHDS are unrivalled and progress is being made towards its implementation. However, ensuring that its necessary components are in place will also be crucial. The question now centres around bolstering sufficient infrastructure, in tandem with both the public and private sectors, to ensure the highest levels of access, privacy and operability. Going a step further, this year EHS will be exploring how Artificial Intelligence (AI) can accelerate patient centricity in Europe.

Tomislav-Sokol
Tomislav Sokol
Member of the European Parliament
Maya-Matthews
Maya Matthews
Deputy Director for Digital, EU4Health and Health Systems Modernisation at DG SANTE
Sanidad.-Enrique-Terol
Enrique Terol
Health Counsellor, Spanish Permanent Representation to the EU
Dipak-Kalra
Dipak Kalra
President, The European Institute for Innovation through Health Data
Jose
José Peres
Senior Coordinator of the National Associations Council at EuropaBio
Menno-Kok
Menno Kok
Managing Director, EIT Health

11:00 – 11:15

COFFEE BREAK

11:15 – 11:25

► Watch the replay

KEYNOTE ADDRESS WITH DR. GAUDENZ SILBERSCHMIDT ON ENHANCED PARTNERSHIPS FOR GLOBAL HEALTH

GAUDENZ-SILBERSCHMIDT-scaled-1
Dr. Gaudenz Silberschmidt
Director, Health and Multilateral Partnerships at the WHO

11:25 – 12:25

► Watch the replay

STRENGTHENING PUBLIC, PRIVATE, ACADEMIA, AND TECH PARTNERSHIPS TO ADVANCE R&D FOR UNMET NEEDS

For R&D to flourish and engender scientific breakthroughs, a conducive environment is needed. Some countries are beginning to create ecosystems for healthcare innovation, creating essential links between the scientific community, big tech, governments, and the public-private sectors. This will allow them to develop and operationalise new treatments in record time. How can the EU keep up with other regions and what steps are needed for a coordinated response?

Emer-Cooke
Emer Cooke
Executive Director of the European Medicines Agency
Irene-Norstedt
Irene Norstedt
Director People Directorate, DG Research and Innovation European Commission
Yann-Le-Cam-2023-1024x683-1
Yann Le Cam
CEO, Eurordis
Adam-Photo-High-Res-scaled
Adam Hacker
Director and Global Head Regulatory Affairs at CEPI
Charlotte-Marchandise-Cropped
Charlotte Marchandise
Executive Director at the European Public Health Association (EUPHA)
Tamsin-Rose
Tamsin Rose
EU Health Reporter

12:25 – 13:30

► Watch the replay

ENSURING SUSTAINABLE HEALTHCARE SYSTEMS THROUGH THE "ONE HEALTH" APPROACH

With a global population that is both growing and ageing, health systems will come under increased pressure. By considering a wider set of contributory factors for healthcare such as healthy nutrition, sustainable food, environmental, agricultural, fisheries and climate policies, we can foster resilience. The COVID-19 pandemic, other disease outbreaks and their societal and economic costs highlight the urgency of applying a One Health approach across all sectors.

1680721766173
Laurent Muschel
Acting Director-General of HERA
Montanes-Carlos
Carlos Montañés
Executive Vice-President, HIPRA
Andrea-Corazza
Andrea Corazza
Senior Director, Policy & Government Affairs Europe, Novavax
Josep-figueras-e1679520382613
Josep Figueras
Director and Cofounder of the European Observatory on Health Systems and Policies
Sara-Cerdas
Sara Cerdas
Member of the European Parliament
Sarah-Taissir
Sarah-Taïssir Bencharif
EU Health Journalist

13:35 – 14:30

NETWORKING LUNCH

14:30 – 15:45

► Watch the replay

A PHARMA STRATEGY TO FOSTER EUROPE'S COMPETITIVENESS ON THE GLOBAL SCALE?

Europe has all the ingredients to drive innovation. It is very attractive for biopharmaceuticals, and has a highly skilled workforce, as well as promising drugs and treatments, especially in the field of rare diseases. However, the pandemic has highlighted the vulnerability of our supply chains and the need to make them more resilient. Among other concerns, there is a need to reform the healthcare sector to optimise budgets and sustainability. We need real data to highlight drug efficacy and increase population and market access. Ensuring that we have the right environment for innovation, supported by strong industrial policy, is critical to continue to foster investment in Europe.

Pernille-Weiss
Pernille Weiss
Member of the European Parliament
Anca-Toma
Anca Toma
Executive Director of the European Patients’ Forum
Massimo-Visentin-Pfizer
Massimo Giorgio Visentin
Eastern Europe Cluster President, Pfizer
Francesca-Colombo
Francesca Colombo
Head of the Health Division, OECD
nathalie-moll-website-scaled
Nathalie Moll
Director General, EFPIA
Mariam-Zaidi-scaled
Mariam Zaidi
Euronews, Euractiv, CNBC Presenter

15:45 – 16:00

► Watch the replay

STRATEGIC COMPETITIVENESS OF EUROPE'S PHARMACEUTICAL INDUSTRY: A MEMBER STATES' PERSPECTIVE

csm_Martin_Kocher_4b8a2e0779
Martin Kocher
Minister for Labour and Economy, Austria
Mariam-Zaidi-scaled
Mariam Zaidi
Euronews, Euractiv, CNBC Presenter

16:00 – 17:15

► Watch the replay

REVITALISING EUROPE'S PHARMACEUTICAL LEGISLATION: PRIORITISING PATIENT ACCESS AND INNOVATION

At the core of Europe’s pharmaceutical legislative reform lies a steadfast commitment to enhancing and expediting patient access to vital healthcare solutions. This unwavering dedication hinges on the level of investment in innovation across the region, encompassing various aspects such as the management of clinical trials and primary/raw data, addressing unmet medical needs, optimizing manufacturing processes for greater efficiency, and establishing a globally competitive regulatory framework coupled with prudent monitoring of supply chains.

Jeffrey-Francer
Jeffrey Francer
Vice President, Global Regulatory Affairs Policy, Eli Lilly
Prof.-Karl-Broich
Prof. Karl Broich
President, Federal Institute for Drugs and Medical Devices
Haseeb-Ahmad
Haseeb Ahmad
President, Europe at Novartis
Dolors-Montserrat
Dolors Montserrat
Member of the European Parliament
Elizabeth-Kuiper
Elizabeth Kuiper
Associate Director, European Policy Centre
Claire-Paquet
Prof. Claire Paquet
Neurologist, Assistance Publique – Hôpitaux de Paris
Mariam-Zaidi-scaled
Mariam Zaidi
Euronews, Euractiv, CNBC Presenter

17:15 – 17:25

► Watch the replay

EXCLUSIVE INTERVIEW ON THE IMPACT OF DEMOGRAPHIC CHALLENGES IN HEALTHCARE

Colin-Scicluna-portrait_c
Colin Scicluna
Head of Cabinet of Vice President Šuica
Giedre-Peseckyte-scaled-e1670249364391
Giedrė Peseckytė
EU Health Reporter, Euractiv

17:25 – 17:35

► Watch the replay

KEYNOTE ADDRESS

giorgos_rossides
Giorgos Rossides
Head of Cabinet of Commissioner Kyriakides

17:35 – 17:40

CLOSING REMARKS

ARNAUD-THYSEN
Arnaud Thysen
Director General, European Business Summits